Latest News

Remotely possible

October 20, 2020

When did the COVID-19 pandemic first make an impact on your life? March 10? That was the day the University of Cincinnati decided to change something it has excelled at for 200 years. Teaching. Educating. That day UC announced that all lectures in classrooms, experiments in labs or designing in studios would be suspended. Students started what was expected to be just an extended spring break, but then 12 days later all courses had gone virtual to protect the university community and stop the virus’s spread.

Fox 19: Optimize your well-being

October 15, 2020

Sian Cotton, PhD, director of the UC Center for Integrative Health and Wellness, and UC family medicine professor, spoke with Fox 19 about using mindfulness techniques to cope in the midst of a stressful COVID-19 impacted world. Cotton explains how a mindfulness practice can help increase our focus and reduce our ability to not waste time. To be focused in the moment allows us to attend to the task at hand and get the job done with time to enjoy life, explains Cotton.

Fox 19: UC students commended for their actions, safety to keep...

October 9, 2020

Chris Lewis, MD, vice provost for academic affairs at UC, spoke with a reporter from Fox 19 about an increase in COVID-19 cases on the UC campus. Lewis was able to provide some context. "Considering we have a campus of 46,000 students plus and 12,000 plus faculty and staff, I would say that’s darn good,” explained Lewis, also an assistant professor of family medicine in the UC College of Medicine and a UC Health physician. Since the pandemic began, the university says it has had 585 total positive COVID-19 cases. 567 of those cases were among the students while 18 were employees. But a recent rise in cases shows 184 infected students live on-campus and 383 who do not. “We’ve seen a little bit of a pattern of a mid-week spike that we attribute to likely events, you know, off-campus on the weekends," explained Lewis. "People just tend to be more social.”

Contagion Live: Targeting Lung Blood Vessel Inflammation in...

September 30, 2020

Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed by a reporter for Contagion Live about a new phase 2 clinical trial UC and UC Health are conducting using the drug razuprotafib, to lessen inflammation of the blood vessels in COVID-19 patients. Razuprotafib activates a key pathway for stabilizing blood vessels in the lungs and may prevent or treat respiratory distress in COVID-19 patients.

Load More
Debug Query for this